Studies_on_the_cellular_origin_of_neurothekeoma:_clinical,_light_microscopic,_immunohistochemical,_and_ultrastructural_observations._The_clinical,_histopathologic,_and_immunohistochemical_features_of_11_cases_of_neurothekeoma_are_reported._One_case_was_examined_by_electron_microscopy._The_mean_age_of_the_patients_was_27.1_years;_the_study_comprised_eight_female_and_three_male_patients._Most_lesions_were_nondescript_papules_and_located_on_the_upper_part_of_the_body,_seven_cases_of_neurothekeoma_on_the_head._Eight_cases_were_classified_as_cellular_neurothekeoma_on_the_basis_of_a_striking_fascicular_pattern_and_three_cases_as_myxomatous_neurothekeoma_because_of_prominent_myxoid_stromal_change._All_cellular_neurothekeomas_failed_to_express_S-100_protein,_whereas_the_three_myxomatous_types_were_strongly_positive_for_this_marker._Other_than_vimentin,_there_was_no_significant_immunoreactivity_with_other_immunohistochemical_markers._Ultrastructural_study_of_one_case_of_cellular_neurothekeoma_was_inconclusive_for_cell_type_although_a_perineurial_origin_could_not_be_excluded._On_the_basis_of_these_results,_we_conclude_that_cellular_neurothekeoma_differs_from_myxomatous_neurothekeoma_not_only_by_clinical_and_histologic_findings_but_also_by_immunoreactivity_with_S-100_protein._These_findings_also_suggest_the_existence_of_two_distinct_subtypes_of_neurothekeoma_and_possible_origin_of_the_two_variants_of_neurothekeoma_from_different_cell_types_or_at_least_variation_in_phenotypic_expression_of_a_common_cell_type._On_the_other_hand,_it_cannot_be_excluded_that_these_two_variants_are_different_stages_in_the_natural_history_of_neurothekeoma.